I believe what RD is saying is that ya'll are misisng a major point, namely that it is the very presence of price controls that is causing this lag, thereby hurting the average European.
-================================
For someone who calls himself a professor, you are not very good at critical thinking.
The prices of many common drugs are three to ten times as high in the US. In Europe, medical plans cover a share of the costs of drugs, so what we have is a few Europeans that cannot buy new drugs (that are not necessarily BETTER drugs), while in the US we have many people who could be helped by drugs, but cannot afford them, such as hypertension drugs that sell for over $2.00 per pill.
Whether the European is "average" or not is immaterial, as no one can buy an unapproved drug in Europe, and the doctors will be unlikely to have been made aware of its existence.
A lot of these "new" drugs are simply reformulated versions of drugs whose patents have run out. Antacids at $8.00 per pill that for most people could be replaced with the same results with something as simple as Maalox.